Jian Li

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

Deyu Chen, Chaoming Mao, Yuepeng Zhou, 2021, BMC Cancer.

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Deyu Chen, Yuepeng Zhou, Dongfang Dai, 2024, Technology in cancer research & treatment.